1,3-Dihydroxyacridone derivatives as inhibitors of herpes virus replication

Antiviral Research

Volumn 45, Issue 2, 2000, Pages 123-134

  Akanitapichat, P ^a,b   Lowden, C T ^a   Bastow, K F ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b Faculty of Science   (Thailand)

Author keywords

Acridone; Antiviral; Topoisomerase II

Indexed keywords

1,3,7 TRIHYDROXYACRIDONE; 2,3 BIS(3,5 DIOXO 1 PIPERAZINYL)BUTANE; 7 CHLORO 1,3 DIHYDROXYACRIDONE; ACLARUBICIN; ACRIDONE DERIVATIVE; AMSACRINE; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; DNA TOPOISOMERASE (ATP HYDROLYSING); ETOPOSIDE; GYRASE INHIBITOR; PROTEIN KINASE C; UNCLASSIFIED DRUG; VIRUS DNA;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DRUG SELECTIVITY; DRUG SYNTHESIS; DRUG TARGETING; EMBRYO; EMBRYO CELL; ENZYME INHIBITION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; LUNG FIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; PROTON NUCLEAR MAGNETIC RESONANCE; VERO CELL; VIRUS REPLICATION;

ACRIDINES; ANIMALS; CELL LINE; DNA TOPOISOMERASES, TYPE II; DNA, VIRAL; ENZYME INHIBITORS; HERPESVIRUS 1, HUMAN; HUMANS; PLAQUE ASSAY; VIRAL PROTEINS; VIRUS REPLICATION;

HERPES; HERPESVIRIDAE; HUMAN HERPESVIRUS 5; SIMPLEXVIRUS;

EID: 0034012992     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(00)00068-1     Document Type: Article

References (33)

1. Akanitapichat, P., Bastow, K.F., unpublished observation.
2. P. Akanitapichat K.F. Bastow Antiviral agents, DNA M.E. Wolf Burger’s Medicinal Chemistry and Drug Discovery 1997 Wiley New York 497 549
3. T. Andoh R. Ishida Catalytic inhibitors of DNA topoisomerase II Biochim. Biophys. Acta 1400 1998 155 171
4. M. Baba Cellular targets as alternative targets for inhibition of HIV-1 Antiviral Res. 33 1997 141 152
5. K.F. Bastow D.D. Derse Y.C. Cheng Susceptibility of phosphonoformic acid-resistant herpes simplex virus variants to arabinosylucleosides and aphidicolin Antimicrob. Agents Chemother. 23 1983 914 917
6. K.F. Bastow J. Bouchard X.J. Ren Y.C. Cheng Synthesis of dihydrofolate reductase and metabolism of related RNA in a methotrexate resistant human cell line infected with herpes simplex virus type 2 Virology 149 1986 199 207
7. K.F. Bastow M. Itoigawa H. Furukawa Y. Kashiwada I.D. Bori L.M. Ballas K.-H. Lee Antiproliferative actions of 7-substituted 1,3-dihydroxyacridones; possible involvement of DNA topoisomerase II and protein kinase C as biochemical targets Bioorg. Med. Chem. 2 1994 1403 1411
8. S.N. Ebert S.S. Shtrom M.T. Muller Topoisomerase II cleavage of herpes simplex virus type I DNA is replication dependent J. Virol. 64 1990 4059 4066
9. S.N. Ebert D. Subramanian S.S. Shtrom I.K. Chung D.S. Parris M.T. Muller Association between the p170 form of human topoisomerase II and progeny viral DNA in cells infected with herpes simplex virus type 1 J. Virol. 68 1994 1010 1020
10. A. Erice Resistance of human cytomegalovirus to antiviral drugs Clin. Microbiol. Rev. 12 1999 286 297
11. S.J. Froelich-Ammon N. Osheroff Topoisomerase poisons: harnessing the dark side of enzyme mechanism J. Biol. Chem. 270 1995 21429 21432
12. O. Hammarsten X. Yao P. Elias Inhibition of topoisomerase II by ICRF-193 prevents efficient replication of herpes simplex virus type 1 J. Virol. 70 1996 4523 4529
13. F.L. Homa J.C. Brown Capsid assembly and DNA packaging in herpes simplex virus Med. Virol. 7 1997 107 122
14. J. Hlubucek E. Ritchie W.C. Taylor A synthesis of acronycine Aust. J. Chem. 23 1970 1881 1886
15. Y.-H. Hsiang H.-Y. Wu L.F. Liu Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells Cancer Res. 48 1988 3230 3235
16. E.-S. Huang J.D. Benson S. Huong B.C. Wilson C. van der Horst Irreversible inhibition of human cytomegalovirus replication by topoisomerase II inhibitor, etoposide: a new strategy for the treatment of human cytomegalovirus infection Antiviral Res. 17 1992 17 32
17. I. Ishida T. Miki T. Narita R. Yui M. Sato K.R. Utsumi K. Tanabe T. Andoh Inhibition of intracellular topoisomerase II by antitumor bis 2, 6-dioxopiperazine derivatives: Mode of cell growth inhibition distinct from that of cleavable complex forming type inhibitors Cancer Res. 51 1991 4909 4916
18. Y. Kashiwada G.I. Nonaka I. Nishioka K.J. Lee L. Bori Y. Fukushima K.F. Bastow K.-H. Lee Tannins as potent inhibitors of DNA topoisomerase II in vitro J. Pharm. Sci. 82 1993 487 492
19. M. Kawanishi Topoisomerase I and II activities are required for Epstein–Barr virus replication J. Gen. Virol. 74 1993 2263 2268
20. R.L. Kinter C.R. Brandt Rapid small-scale isolation of herpes simplex virus DNA J. Virol. Methods 48 1994 189 196
21. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
22. L.F. Liu K.G. Miller Eukaryotic DNA topoisomerases: two forms of type I DNA topoisomerases from HeLa cell nuclei Proc. Natl. Acad. Sci. USA 78 1981 3487 3491
23. Y. Nishiyama Herpesvirus genes: molecular basis of viral replication and pathogenicity Nagoya J. Med. Sci. 59 1996 107 119
24. Y. Nishiyama H. Fujioka T. Tsurumi N. Yamamoto K. Maeno S. Yoshida K. Shimokata Effects of the epipodophllotoxin VP-16-213 on herpes simplex virus type 2 replication J. Gen. Virol. 68 1987 913 918
25. J. Roca R. Ishida J.M. Berger T. Andoh J.C. Wang Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp Proc. Natl. Acad. Sci. USA 91 1994 1781 1785
26. G. Sherman S.L. Bachenheimer Characterization of intranuclear capsids made by ts morphogenic mutants of HSV-1 Virology 163 1988 471 480
27. P. Skehan R. Storeng D. Scudiero A. Monks J. McMahon D. Vistica J.T. Warren H. Bokesch S. Kenny M.R. Boyd New colorimetric cytotoxicity assay for anticancer-drug screening J. Natl. Cancer Inst. 82 1990 1107 1112
28. B.S. Sorensen J. Sinding A.H. Andersen J. Alsner P.B. Jensen O. Westergaard Mode of action of topoisomerase II-targeting agents at a specific DNA sequence: uncoupling the DNA binding, cleavage and religation events J. Mol. Biol. 228 1992 778 786
29. E.M. Southern Detection of specific sequences among DNA fragments separated by gel electrophoresis J. Mol. Biol. 98 1975 503 517
30. Vance, J.R., 1998. Biochemical and biological evaluation of 7-substituted-1,3-dihydroxyacridones as mammalian DNA topoisomerase inhibitors. In: PhD Thesis. University of North Carolina at Chapel Hill. Chap. 3, pp. 45–54.
31. J.R. Vance K.F. Bastow Inhibition of DNA topoisomerase II catalytic activity by the antiviral agents 7-chloro,1,3-dihydroxyacridone and 1,3,7-trihydroxyacridone Biochem. Pharmacol. 58 1999 703 708
32. J.C. Wang DNA topoisomerases Annu. Rev. Biochem. 65 1996 635 692
33. R.D. Woessner M.R. Mattern C.K. Mirabelli R.K. Johnson F.H. Drake Proliferation-and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells Cell Growth Differ 2 1991 209 214